Innovation Pharmaceuticals Inc (IPIX)

[Chronic]

Plenty, I got the Galera info from their press release:

In the intent-to-treat population, the 90 milligram (mg) dose of GC4419 met its primary endpoint, demonstrating a highly significant (p=0.024), clinically meaningful and dose-dependent reduction in the duration of SOM as defined by the World Health Organization as Grade 3 or 4